199 related articles for article (PubMed ID: 24566034)
1. [Venous thromboembolism and cancer].
Meyer G
Rev Pneumol Clin; 2014; 70(1-2):91-4. PubMed ID: 24566034
[TBL] [Abstract][Full Text] [Related]
2. Role of palliative low-molecular-weight heparin for treating venous thromboembolism in patients with advanced cancer.
Tran QN
Am J Hosp Palliat Care; 2010 Sep; 27(6):416-9. PubMed ID: 20197558
[TBL] [Abstract][Full Text] [Related]
3. [Risk of venous thromboembolism in cancer patients: Reality, actuality and perspectives].
Gerotziafas GT; Elalamy I
Bull Cancer; 2016 Sep; 103(9):764-75. PubMed ID: 27481723
[TBL] [Abstract][Full Text] [Related]
4. Long-term use of different doses of low-molecular-weight heparin versus vitamin K antagonists in the treatment of venous thromboembolism.
Romera-Villegas A; Cairols-Castellote MA; Vila-Coll R; Martí-Mestre X; Colomé E; Iguaz I
Ann Vasc Surg; 2010 Jul; 24(5):628-39. PubMed ID: 19932949
[TBL] [Abstract][Full Text] [Related]
5. Treatment of venous thromboembolism in cancer patients.
Petralia GA; Kakkar AK
Semin Thromb Hemost; 2007 Oct; 33(7):707-11. PubMed ID: 18000799
[TBL] [Abstract][Full Text] [Related]
6. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
[TBL] [Abstract][Full Text] [Related]
7. Compliance with recommendations of clinical practice in the management of venous thromboembolism in cancer: the CARMEN study.
Sevestre MA; Belizna C; Durant C; Bosson JL; Vedrine L; Cajfinger F; Debourdeau P; Farge D;
J Mal Vasc; 2014 May; 39(3):161-8. PubMed ID: 24746736
[TBL] [Abstract][Full Text] [Related]
8. [Venous thromboembolism and cancer].
Meyer G
Rev Prat; 2015 Feb; 65(2):216-9. PubMed ID: 25939227
[TBL] [Abstract][Full Text] [Related]
9. The treatment of venous thromboembolism in patients with cancer.
Prandoni P
Intern Emerg Med; 2010 Oct; 5 Suppl 1():S27-30. PubMed ID: 20865471
[TBL] [Abstract][Full Text] [Related]
10. [Venous thrombo-embolic disease in cancer. Low molecular weight heparin indications].
Nou M; Laroche JP
J Mal Vasc; 2016 May; 41(3):197-204. PubMed ID: 27146099
[TBL] [Abstract][Full Text] [Related]
11. [Cancer and venous thromboembolism].
Meyer G; Belmont L
Rev Mal Respir; 2011 Apr; 28(4):443-52. PubMed ID: 21549900
[TBL] [Abstract][Full Text] [Related]
12. A retrospective analysis of the effectiveness of low molecular weight heparin for venous thromboembolism prophylaxis in trauma patients.
Gritsiouk Y; Hegsted DA; Schlesinger P; Gardiner SK; Gubler KD
Am J Surg; 2014 May; 207(5):648-51; discussion 651-2. PubMed ID: 24560359
[TBL] [Abstract][Full Text] [Related]
13. [Cancer-associated venous thromboembolic recurrence: disregard of treatment recommendations].
Mahé I; Chidiac J
Bull Cancer; 2014 Mar; 101(3):295-301. PubMed ID: 24691192
[TBL] [Abstract][Full Text] [Related]
14. Venous thromboembolism in patients with advanced cancer under palliative care: additional risk factors, primary/secondary prophylaxis and complications observed under normal clinical practice.
Soto-Cárdenas MJ; Pelayo-García G; Rodríguez-Camacho A; Segura-Fernández E; Mogollo-Galván A; Giron-Gonzalez JA
Palliat Med; 2008 Dec; 22(8):965-8. PubMed ID: 18952751
[TBL] [Abstract][Full Text] [Related]
15. Long-term therapy with low-molecular-weight heparin in cancer patients with venous thromboembolism.
Marchena PJ; Nieto JA; Guil M; García-Bragado F; Rabuñal R; Boccalon H; Trujillo-Santos J; Monreal M;
Thromb Haemost; 2012 Jan; 107(1):37-43. PubMed ID: 22116496
[TBL] [Abstract][Full Text] [Related]
16. [Prophylaxis and treatment of venous thromboembolism in cancer patients. Clinical value of low-molecular-weight heparins].
Kreher S; Riess H
Internist (Berl); 2014 Apr; 55(4):448-54. PubMed ID: 24599489
[TBL] [Abstract][Full Text] [Related]
17. Treatment and secondary prevention of venous thromboembolism in cancer patients. Current strategies and new therapeutic options.
Ay C; Pabinger I
Hamostaseologie; 2012; 32(2):139-44. PubMed ID: 21822525
[TBL] [Abstract][Full Text] [Related]
18. [Risk factors for recurrent venous thromboembolism].
Rosencher J; Mirault T; Martinez I; Zhu T; Messas E; Emmerich J
Rev Mal Respir; 2011 Apr; 28(4):453-62. PubMed ID: 21549901
[TBL] [Abstract][Full Text] [Related]
19. Clinical presentation and time-course of postoperative venous thromboembolism: Results from the RIETE Registry.
Arcelus JI; Monreal M; Caprini JA; Guisado JG; Soto MJ; Núñez MJ; Alvárez JC;
Thromb Haemost; 2008 Mar; 99(3):546-51. PubMed ID: 18327403
[TBL] [Abstract][Full Text] [Related]
20. Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry.
Gussoni G; Frasson S; La Regina M; Di Micco P; Monreal M;
Thromb Res; 2013 Jan; 131(1):24-30. PubMed ID: 23141849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]